Jan 14, 2026 10:21AM
Apr 30, 2024 08:00AM
Apr 15, 2024 07:00AM
Jan 18, 2024 06:50AM
Jan 18, 2024 06:50AM
Jan 18, 2024 06:50AM
Dec 6, 2023 04:05PM Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City
Nov 29, 2023 07:31AM
Nov 29, 2023 07:30AM
Nov 9, 2023 07:30AM
Oct 24, 2023 08:42AM
Oct 24, 2023 08:40AM
Oct 23, 2023 06:53AM
Oct 23, 2023 06:50AM Eagle Pharmaceuticals Granted Unique J-Code and Pass-Through Status for BARHEMSYS® from CMS
Oct 4, 2023 06:50AM
Sep 11, 2023 06:50AM
Aug 30, 2023 06:50AM
Aug 29, 2023 06:51AM
Aug 29, 2023 06:50AM
Aug 17, 2023 06:50AM
Aug 17, 2023 06:50AM Eagle Pharmaceuticals Reiterates 2023 Adjusted non-GAAP EBITDA and Adjusted non-GAAP E¹ Guidance
Aug 8, 2023 06:50AM
Jul 31, 2023 06:51AM
Jul 31, 2023 06:50AM
Jul 24, 2023 06:50AM
Jun 15, 2023 06:51AM
Jun 15, 2023 06:50AM
Jun 14, 2023 06:51AM Eagle Pharmaceuticals (EGRX) Receives FDA Qualified Infectious Disease Product (QIDP) and Fast-Track Designation for CAL02
Jun 14, 2023 06:50AM
May 11, 2023 06:50AM
May 9, 2023 06:50AM
May 1, 2023 06:52AM
May 1, 2023 06:50AM
Apr 5, 2023 06:55AM
Apr 5, 2023 06:50AM Eagle Pharmaceuticals Reaches Settlement Agreement with Dr. Reddy’s Laboratories Inc. and Dr. Reddy’s Laboratories Ltd. Related to BENDEKA® (bendamustine hydrochloride)
Mar 13, 2023 06:50AM
Jan 10, 2023 02:01PM
Jan 10, 2023 02:00PM
Dec 19, 2022 06:50AM
Dec 19, 2022 06:50AM
Dec 19, 2022 06:50AM
Dec 12, 2022 06:59AM Eagle Pharmaceuticals (EGRX) Reaches Settlement Agreement with Accord Healthcare, Inc. Related to BENDEKA
Dec 12, 2022 06:50AM
Dec 1, 2022 06:50AM
Nov 14, 2022 06:53AM
Nov 14, 2022 06:50AM
Nov 9, 2022 06:50AM
Nov 7, 2022 06:50AM
Oct 12, 2022 06:50AM Eagle Pharmaceuticals (EGRX) Submits IND for CAL02
Oct 12, 2022 06:50AM

322,084 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All